Cypher Genomics

Cypher Genomics, Inc. is a genome informatics company that specializes in automated human genome interpretation software solutions targeted at clinical labs, pharmaceutical companies, and population genomics initiatives. Founded in 2011 and based in La Jolla, California, the company's platform enables clinical laboratories to adjust sensitivity and specificity profiles for developing molecular tests for diagnostic and prognostic purposes. Additionally, it assists pharmaceutical firms in identifying biomarkers from whole genome sequence data, particularly in early-stage drug development studies. Cypher Genomics offers solutions such as Mantis, a software-as-a-service that provides clinical-grade summaries for genomic analyses, and Coral, a biomarker discovery service that integrates genome sequencing with clinical data to aid in therapy development. The company has established strategic partnerships with notable organizations in the field, including Celgene and Illumina. Cypher Genomics is now a subsidiary of Human Longevity, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.